These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18388351)

  • 1. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT; Moschos C; Loutrari H; Kollintza A; Psallidas I; Karabela S; Magkouta S; Zhou Z; Papiris SA; Roussos C; Kalomenidis I
    Am J Respir Crit Care Med; 2008 Jul; 178(1):50-9. PubMed ID: 18388351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sulindac analogue is effective against malignant pleural effusion in mice.
    Moschos C; Psallidas I; Cottin T; Kollintza A; Papiris S; Roussos C; Stathopoulos GT; Giannis A; Kalomenidis I
    Lung Cancer; 2011 Aug; 73(2):171-5. PubMed ID: 21227533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
    Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
    Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
    Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
    Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
    Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine is effective for the malignant pleural effusion associated with lung cancer in mice.
    Cui R; Yoshioka M; Takahashi F; Ishida H; Iwakami S; Takahashi K
    Anticancer Res; 2008; 28(3A):1633-9. PubMed ID: 18630520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of malignant pleural effusion.
    Stathopoulos GT; Kalomenidis I
    Curr Opin Pulm Med; 2009 Jul; 15(4):343-52. PubMed ID: 19387350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.
    Clive AO; Hooper CE; Edey AJ; Morley AJ; Zahan-Evans N; Hall D; Lyburn I; White P; Braybrooke JP; Sequeiros I; Lyen SM; Milton T; Kahan BC; Maskell NA
    PLoS One; 2015; 10(3):e0118569. PubMed ID: 25781025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
    Corey E; Brown LG; Quinn JE; Poot M; Roudier MP; Higano CS; Vessella RL
    Clin Cancer Res; 2003 Jan; 9(1):295-306. PubMed ID: 12538482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for hyperpermeability of tumor vessels in advanced lung adenocarcinoma complicated by pleural effusion.
    Damianovich M; Hout Siloni G; Barshack I; Simansky DA; Kidron D; Dar E; Avivi C; Onn A
    Clin Lung Cancer; 2013 Nov; 14(6):688-98. PubMed ID: 23931900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
    Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
    Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.
    Xie SL; Yang MH; Chen K; Huang H; Zhao XW; Zang YS; Li B
    Cell Biochem Biophys; 2015 Apr; 71(3):1325-33. PubMed ID: 25413961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
    Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
    Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
    PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.